IP Library Assignment 043548/0228
Patent Assignment
Reel/Frame 043548/0228

Security Interest

Recorded: 2017-09-11 Pages: 9
Assignor
EXAGEN DIAGNOSTICS, INC.
Executed: 2017-09-07
Assignee
INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT
777 THIRD AVENUE, 25TH FLOOR, NEW YORK, NEW YORK, 10017
Covered Properties (15)
Methods of Quantifying Methotrexate Metabolites
Patent: 7,563,590 →
Application: 10/232,760 →
Publication: US 2004/0043441
Methods for Direct Detection of Individual Methotrexate Metabolites
Patent: 6,921,667 →
Application: 10/384,066 →
Publication: US 2004/0175834
Diagnosis and Monitoring of Systemic Lupus Erythematosus and of Scleroderma
Patent: 7,390,631 →
Application: 10/489,219 →
Publication: US 2005/0037441
Diagnosing and Monitoring Inflammatory Diseases by Measuring Complement Components on White Blood Cells
Patent: 7,585,640 →
Application: 10/545,052 →
Publication: US 2007/0026387
Identification and Monitoring of Systemic Lupus Erythematosus
Patent: 7,588,905 →
Application: 10/552,177 →
Publication: US 2007/0178536
Monitoring Immunologic, Hematologic and Inflammatory Diseases
Patent: 8,080,382 →
Application: 10/866,509 →
Publication: US 2005/0042602
Methods for Optimizing Clinical Responsiveness to Methotrexate Therapy Using Metabolite Profiling and Pharmacogenetics
Patent: 7,582,282 →
Application: 10/927,904 →
Publication: US 2005/0112627
Real Time Method of Detecting Acute Inflammatory Conditions
Patent: 7,361,517 →
Application: 11/101,898 →
Publication: US 2005/0282234
Methods for Predicting Methotrexate Polyglutamate Levels Using Pharmacogenetics
Patent: 7,695,908 →
Application: 11/152,128 →
Publication: US 2006/0057609
Process for diagnosing rheumatic diseases
Patent: 8,999,921 →
Application: 11/597,515 →
Publication: US 2009/0155822
Methods and Devices Relating to Estimating Classifier Performance
Patent: 7,698,071 →
Application: 12/502,979 →
Publication: US 2009/0276384
Identification and Monitoring of Systemic Lupus Erythematosus
Patent: 8,126,654 →
Application: 12/538,001 →
Publication: US 2009/0299948
Methods for Monitoring Methotrexate Therapy
Patent: 9,261,509 →
Application: 13/810,683 →
Publication: US 2013/0230865
Methods for Diagnosing Systemic Lupus Erythematosus
Application: 13/992,086 →
Publication: US 2013/0309698
Methods for treating and diagnosing Systemic Lupus Erythematosus
Application: 14/767,461 →
Publication: US 2015/0369824
Related Assignments (20)
Other recorded transfers of the patents in this record — the chain of ownership.
Short-Form Patent Security Agreement Oct 15, 2013
From: EXAGEN DIAGNOSTICS, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 031414/0660 →
Assignment of Assignor's Interest Aug 13, 2015
From: DERVIEUX, THIERRY; BARKEN, DERREN
To: EXAGEN DIAGNOSTICS, INC.
Reel/Frame 036320/0038 →
Release of Security Interest Dec 29, 2015
From: BANK OF AMERICA, N.A.
To: PROMETHEUS LABORATORIES INC.
Reel/Frame 037378/0464 →
Assignment of Assignor's Interest Jul 20, 2017
From: DERVIEUX, THIERRY
To: EXAGEN DIAGNOSTICS, INC.
Reel/Frame 043058/0203 →
Assignment of Assignor's Interest Jul 25, 2017
From: HARRIS, COLE
To: EXAGEN DIAGNOSTICS, INC.
Reel/Frame 043093/0257 →
Release of Security Interest Sep 1, 2017
From: CYPRESS BIOSCIENCE INC.
To: EXAGEN DIAGNOSTICS, INC.
Reel/Frame 043747/0382 →
Release of Security Interest Sep 7, 2017
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: EXAGEN DIAGNOSTICS, INC.
Reel/Frame 043784/0828 →
Merger Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
Assignment of Assignor's Interest Jun 13, 2019
From: HARRIS, COLE
To: EXAGEN DIAGNOSTICS, INC.
Reel/Frame 049458/0193 →
Corrective Assignment to Correct the English Translation to Show the Full and Correct New Name in Section 51. Previously Recorded at Reel: 049391 Frame: 0756. Assignor(S) Hereby Confirms the Merger. Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
Assignment of Assignor's Interest Aug 26, 2019
From: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
To: PRECISION IBD, INC.
Reel/Frame 050166/0001 →
Change of Name Sep 20, 2019
From: EXAGEN DIAGNOSTICS, INC.
To: EXAGEN INC.
Reel/Frame 050456/0201 →
Change of Name Oct 17, 2019
From: PRECISION IBD, INC.
To: PROMETHEUS BIOSCIENCES, INC.
Reel/Frame 050886/0942 →
Corrective Assignment to Correct the Patent Number 16062921 Previously Recorded on Reel 049391 Frame 0756. Assignor(S) Hereby Confirms the Patent Number Should Have Been 16062912. Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
Corrective Assignment to Correct the Patent Number 16062921 Previously Recorded on Reel 049391 Frame 0756. Assignor(S) Hereby Confirms the Patent Number Should Have Been 16062912. Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
Assignment of Assignor's Interest Oct 7, 2021
From: PROMETHEUS BIOSCIENCES, INC.
To: PROMETHEUS LABORATORIES INC.
Reel/Frame 057730/0993 →
Assignment of Assignor's Interest Nov 3, 2021
From: PROMETHEUS LABORATORIES INC.
To: EXAGEN INC.
Reel/Frame 058007/0978 →
Release of Security Interest Apr 25, 2025
From: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
To: EXAGEN INC.
Reel/Frame 070951/0040 →
Security Interest Apr 25, 2025
From: EXAGEN INC.
To: PERCEPTIVE CREDIT HOLDINGS IV, LP
Reel/Frame 070952/0802 →
Release of Security Interest Sep 4, 2025
From: NEW MEXICO MEZZANINE PARTERSN, L.P.; NEW MEXICO CO-INVESTMENT FUND, L.P.
To: EXAGEN INC.
Reel/Frame 072159/0497 →